131 related articles for article (PubMed ID: 9838354)
1. Blockade of angiotensin II AT 1 receptor reduces hematocrit in patients with posttransplant erythrocytosis.
Tsang WK; Tong KL; Chan HW
Transplant Proc; 1998 Nov; 30(7):3072-3. PubMed ID: 9838354
[No Abstract] [Full Text] [Related]
2. Losartan, an angiotensin II type 1 receptor antagonist, lowers hematocrit in posttransplant erythrocytosis.
Julian BA; Brantley RR; Barker CV; Stopka T; Gaston RS; Curtis JJ; Lee JY; Prchal JT
J Am Soc Nephrol; 1998 Jun; 9(6):1104-8. PubMed ID: 9621296
[TBL] [Abstract][Full Text] [Related]
3. Treatment with losartan in kidney transplant recipients with posttransplant erythrocytosis.
Iñigo P; Torregrosa JV; Campistol JM; Oppenheimer F
Transplant Proc; 1999 Sep; 31(6):2321. PubMed ID: 10500598
[No Abstract] [Full Text] [Related]
4. Effects of losartan on the treatment of posttransplant erythrocytosis.
Navarro JF; García J; Macía M; Mora C; Chahin J; Gallego E; Méndez ML; del Castillo N
Clin Nephrol; 1998 Jun; 49(6):370-2. PubMed ID: 9696433
[TBL] [Abstract][Full Text] [Related]
5. Successful long-term treatment of post-transplant erythrocytosis with losartan.
Midtvedt K; Stokke ES; Hartmann A
Nephrol Dial Transplant; 1996 Dec; 11(12):2495-7. PubMed ID: 9017632
[No Abstract] [Full Text] [Related]
6. Losartan versus ramipril in the treatment of postrenal transplant erythrocytosis.
Hortal L; Fernández A; Vega N; Rodríguez JC; Losada A; Lorenzo M; Plaza C; Palop L
Transplant Proc; 1998 Aug; 30(5):2127-8. PubMed ID: 9723415
[No Abstract] [Full Text] [Related]
7. The effect of losartan on posttransplant erythrocytosis.
Colak T; Emiroglu R; Karakayali H; Haberal M
Transplant Proc; 2001; 33(1-2):2014-5. PubMed ID: 11267606
[No Abstract] [Full Text] [Related]
8. Losartan and renal transplantation.
Horn S; Holzer H; Horina J
Lancet; 1998 Jan; 351(9096):111. PubMed ID: 9439500
[No Abstract] [Full Text] [Related]
9. [Treatment of post kidney transplantation erythrocytosis (PTE) with ACE inhibitors].
Morale W; Puliatti C; Veroux P; Veroux M; Valvo C; Cappello D; Puliatti D; Francesco L
Minerva Urol Nefrol; 2002 Jun; 54(2):145-8. PubMed ID: 12070465
[TBL] [Abstract][Full Text] [Related]
10. Benefit of angiotensin II receptor blockade in the treatment of posttransplant polycythemia in renal transplant recipients.
Kupin W; Venkat KK; Goggins M; Abouljoud M; Escobar F; Mozes M
Transplant Proc; 1997; 29(1-2):207-8. PubMed ID: 9122965
[No Abstract] [Full Text] [Related]
11. Losartan, an angiotensin-II receptor antagonist, reduces hematocrits in kidney transplant recipients with posttransplant erythrocytosis.
Klaassen RJ; van Gelder T; Rischen-Vos J; Deinum J; Man in't Veld AJ; Weimar W
Transplantation; 1997 Sep; 64(5):780-2. PubMed ID: 9311722
[TBL] [Abstract][Full Text] [Related]
12. Post-transplant erythrocytosis refractory to ACE inhibitors and angiotensin receptor blockers.
Vishnu P; Moreno Vanegas Y; Wadei HM; Rivera CE
BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29954763
[TBL] [Abstract][Full Text] [Related]
13. New insights and treatment in posttransplant polycythemia (erythrocytosis) of renal recipients.
Sauron C; Berthoux P; Berthoux F; Alamartine E; Diab N; Broyet C; Hacini J
Transplant Proc; 1993 Feb; 25(1 Pt 2):1032-3. PubMed ID: 8382847
[No Abstract] [Full Text] [Related]
14. Angiotensin II type 1 (AT1) receptor antagonists in the treatment of hypertension after renal transplantation.
Holgado R; Anaya F; Del Castillo D
Nephrol Dial Transplant; 2001; 16 Suppl 1():117-20. PubMed ID: 11369838
[TBL] [Abstract][Full Text] [Related]
15. A prospective, randomized, open labeled crossover trial of fosinopril and theophylline in post renal transplant erythrocytosis.
Trivedi H; Lal SM
Ren Fail; 2003 Jan; 25(1):77-86. PubMed ID: 12617335
[TBL] [Abstract][Full Text] [Related]
16. Long-term anti-proteinuric effect of Losartan in renal transplant recipients treated for hypertension.
Calviño J; Lens XM; Romero R; Sánchez-Guisande D
Nephrol Dial Transplant; 2000 Jan; 15(1):82-6. PubMed ID: 10607772
[TBL] [Abstract][Full Text] [Related]
17. Regression of left ventricular hypertrophy by AT1 receptor blockade in renal transplant recipients.
Klingbeil AU; Müller HJ; Delles C; Fleischmann E; Schmieder RE
Am J Hypertens; 2000 Dec; 13(12):1295-300. PubMed ID: 11130774
[TBL] [Abstract][Full Text] [Related]
18. Losartan reduces hematocrit in patients with chronic obstructive pulmonary disease and secondary erythrocytosis.
Vlahakos DV; Marathias KP; Kosmas EN
Ann Intern Med; 2001 Mar; 134(5):426-7. PubMed ID: 11242510
[No Abstract] [Full Text] [Related]
19. Effects of angiotensin converting enzyme inhibitor and angiotensin II receptor antagonist therapy in hypertensive renal transplant recipients.
Kim W; Lee S; Kang SK; Yu HC; Cho BH; Park SK
Transplant Proc; 2002 Dec; 34(8):3223-4. PubMed ID: 12493427
[No Abstract] [Full Text] [Related]
20. Effects of losartan or enalapril on hemoglobin, circulating erythropoietin, and insulin-like growth factor-1 in patients with and without posttransplant erythrocytosis.
Wang AY; Yu AW; Lam CW; Yu LM; Li PK; Goh J; Lui SF
Am J Kidney Dis; 2002 Mar; 39(3):600-8. PubMed ID: 11877580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
